Region Vaesterbotten — Sponsor Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

5 Recruiting

2 Completed trials

3 Countries active

34 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I/II

Phase III/IV

Phase IV

Phase III: 4 Phase II: 1 Phase I/II: 1 Phase III/IV: 1 Phase IV: 3

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Prostate cancer 1

Top IMPs

APALUTAMIDE 2 ENZALUTAMIDE 2 177LU-PSMA-I&T 1 DENGUE VIRUS, SEROTYPE 2, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 1, SURFACE PROTEINS, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 3, SURFACE PROTEINS, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 4, SURFACE PROTEINS, LIVE, ATTENUATED 1 DEXAMETHASONE PHOSPHATE 1 FLUTEMETAMOL (18F) 1 GADOBUTROL 1 GADOTERIC ACID 1 GLUCAGON 1 HUMAN NORMAL IMMUNOGLOBULIN 1 HYOSCINE BUTYLBROMIDE 1 NIRMATRELVIR 1

All trials

10 total

CYPENZA - A prospective cohort trial on antiandrogens influences on the pharmacokinetics of corticosteroids. Pending

2025-520571-66-00 Phase III 1 country APALUTAMIDE; DEXAMETHASONE PHOSPHATE; ENZALUTAMIDE
Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial Pending

2025-522399-10-00 Phase III 3 countries PREDNISOLONE
Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone … Pending

2025-522756-97-00 Phase II 1 country HUMAN NORMAL IMMUNOGLOBULIN; NIRMATRELVIR; REMDESIVIR
An open non-randomized phase IV trial examining interfering cross-reactivity in serological diagnostics of flavivirus infections in Swedish … Recruiting

2025-520655-92-00 Phase IV 1 country DENGUE VIRUS, SEROTYPE 2, LIVE, ATTENUATED, DENGUE VIRUS, SEROTYPE 2, EXPRESSING…
LOWOX Recruiting

2024-513117-12-00 Phase III/IV 1 country
MRI contrast agent in the spinal canal to investigate transportation of the cerebrospinal fluid in the brain. Recruiting

2024-520146-33-00 Phase I/II 1 country FLUTEMETAMOL (18F); GADOBUTROL
Evaluation of PSMA-PET and mpMRI in high-risk prostate cancer – using histopathologic validation Recruiting

2022-501892-14-00 Phase III 1 country GADOTERIC ACID; GLUCAGON; HYOSCINE BUTYLBROMIDE
A Randomised study comparing Lutetium-177 versus Apalutamide/Enzalutamide/Abiraterone, in metastatic Hormon Sensitive Prostate Cancer in PSM… Recruiting

2022-500570-33-00 Phase III 1 country 177LU-PSMA-I&T; APALUTAMIDE; ENZALUTAMIDE
Efficacy, tolerability and preferences of per oral or subcutaneous methotrexate in patients with early rheumatoid arthritis – a randomised r… Ended

2024-512453-25-00 Phase IV 1 country
Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomize… Ended

2023-510041-16-00 Phase IV 1 country

Showing 1–10 of 10 trials

← All sponsors A–Z